CLINICAL_TRIALS trial_result · 2023-02-08

Clinical Trial Update: Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis [Phase 2]

Phase 2 trial assessing INS1007 in non-cystic fibrosis bronchiectasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Insmed Incorporated | Conditions: Non-Cystic Fibrosis Bronchiectasis | Phase 2 | Status: COMPLETED | Results posted: 2023-02-08